🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchFLOW trial: semaglutide renal outcomes — need advice Page 4

FLOW trial: semaglutide renal outcomes — need advice

Dr.PainCLE Thu, Apr 16, 2026 at 9:08 PM 30 replies 843 viewsPage 4 of 6
SleepDoc_PDX
Member
289
1,234
Sep 2024
Portland, OR
Apr 23, 2026 at 1:59 PM#16

Adding the clinical framing, because it changes how the question reads.

Kidney function labs on renal function — good news for anyone concerned about renal effects:

MarkerBaselineMonth 6Ref Range
eGFR7588>60
Creatinine1.11.00.7-1.3
BUN25147-20
UACR6023<30

The FLOW trial demonstrated renal protective effects of semaglutide. My nephrologist is encouraged by the UACR improvement especially.

27 2pete_nash, hank_denver, carlos_SATX and 24 others
Reply Quote Save Share Report
KevinCompounds
VIP Member
5,432
18,234
Dec 2023
Nevada
Apr 24, 2026 at 4:16 AM#17

From the other side of the consultation, briefly. It helps to say which part of this you are uncertain about. A precise question gets a precise answer; a general one gets everybody’s favourite anecdote.

26 1Dr.RaviCardio, jennifer_SEA, tyler_CSCS and 23 others
Reply Quote Save Share Report
adam_van
Member
212
890
Nov 2024
Vancouver, CA
Apr 24, 2026 at 6:34 PM#18
KevinCompounds said:
It helps to say which part of this you are uncertain about.

Adding a me-too, because a thread of one person's experience is not much use.

25 0LindaRN_retired, tommy_boulder, hyun_seoul and 22 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
hank_denver
Member
278
1,234
Sep 2024
Denver, CO
Apr 25, 2026 at 8:52 AM#19
KevinCompounds said:
It helps to say which part of this you are uncertain about.

There is a second half to this that has not been said yet. Steady state is the thing most people miss. The terminal half-life is about a week, so every dose step takes four to five weeks to fully express itself. Judging a step at day ten is judging the ascent, not the plateau, and it is the single commonest reason people escalate before they needed to.

24 24fiona_VT, denise_HTX, raj_cambridge and 21 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Apr 25, 2026 at 11:10 PM#20

Moderator note: the sourcing question belongs in the vendor section and has been split out.

2 2PeptideSynthNJ, Dr.KarenChen
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register